Home › Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization
 

Keywords :   


Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization

2016-01-15 11:31:11| Industrial Newsroom - All News for Today

RIYADH, Saudi Arabia - Varian Medical Systems (NYSE: VAR) has announced today its ProBeam proton therapy system is the first such system to receive Saudi FDA medical devices marketing authorization. "We are pleased to have the opportunity to make life-saving proton therapy treatments available to cancer patients...

Tags: system receive therapy saudi

Category:Industrial Goods and Services

Latest from this category

All news
19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »